ACC International Holdings Ltd., Insider at BRAINSTORM CELL THERAPEUTICS INC. (BCLI), bought 6,700 shares at $4.18 ($28K) on 2014-09-29, disclosed to the SEC on 2014-10-01.
Open-market purchase of $28k BCLI by Insider. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.12 | 1,000 | $4K | 14.9% |
| 2 | $4.17 | 500 | $2K | 7.5% |
| 3 | $4.18 | 100 | $418 | 1.5% |
| 4 | $4.22 | 500 | $2K | 7.6% |
| 5 | $4.32 | 1,000 | $4K | 15.6% |
| 6 | $4.08 | 3,600 |
| $15K |
| 52.9% |
| Total | $4.14 avg | 6,700 | $28K | 100% |
| Filing → |
| BCLI | BUY | 2015-10-01 | $22K | — | Filing → |
| BCLI | BUY | 2014-10-15 | $35K | — | Filing → |
| BCLI | BUY | 2014-09-24 | $46K | — | Filing → |